Taking CD4+ memory T cells as an example, BLCA and ESCA patients with high expression of KIF11 and enriched CD4+ memory T cells had a poor prognosis, while CESC patients with high expression of KIF11 and enriched CD4+ memory T cells had a better prognosis. The gene discussed is KIF11; the disease is bladder transitional cell carcinoma.